Last Updated: June 22, 2026

AMPHOTERICIN Drug Patent Profile

Name: AMPHOTERICIN Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Amphotericin, and when can generic versions of Amphotericin launch?

Amphotericin is a drug marketed by Avet Lifesciences, Eugia Pharma, Mylan Labs Ltd, Spil, Abbott, Abraxis Pharm, Teva Parenteral, and Xgen Pharms. and is included in eight NDAs.

The generic ingredient in AMPHOTERICIN is amphotericin b. There are fifteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the amphotericin b profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Amphotericin

A generic version of AMPHOTERICIN was approved as amphotericin b by XGEN PHARMS on April 29^th, 1992.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for AMPHOTERICIN?
What are the global sales for AMPHOTERICIN?
What is Average Wholesale Price for AMPHOTERICIN?

Summary for AMPHOTERICIN

US Patents:	0
Applicants:	8
NDAs:	8
Drug Prices:	Drug price information for AMPHOTERICIN
DailyMed Link:	AMPHOTERICIN at DailyMed

Drug patent expirations by year for AMPHOTERICIN

US Patents and Regulatory Information for AMPHOTERICIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Avet Lifesciences	AMPHOTERICIN B	amphotericin b	INJECTABLE, LIPOSOMAL;INJECTION	215354-001	Jun 2, 2025	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Teva Parenteral	AMPHOTERICIN B	amphotericin b	INJECTABLE;INJECTION	064062-001	Mar 31, 1995		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Spil	AMPHOTERICIN B	amphotericin b	INJECTABLE, LIPOSOMAL;INJECTION	212514-001	Dec 14, 2021	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for AMPHOTERICIN

Amphotericin b price trends?
Liposomal amphotericin b price?
Amphotericin b tablet price?
Amphotericin b price in pakistan?
Liposomal amphotericin b cost?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.